Detalles de la búsqueda
1.
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
J Rheumatol
; 51(5): 479-487, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359937
2.
A retrospective study comparing postoperative opioid prescribing practices in an academic medical centre.
Can Pharm J (Ott)
; 155(5): 277-284, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36081921
3.
Postpartum Analgesia in New Mothers (PAIN) Study: A Survey of Canadian Obstetricians' Post-Delivery Opioid-Prescribing Practices.
J Obstet Gynaecol Can
; 43(8): 957-966.e9, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321248
4.
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials.
J Clin Rheumatol
; 27(8): e482-e490, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32826657
5.
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.
Rheumatol Ther
; 11(3): 563-582, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467912
6.
Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice.
Rheumatol Ther
; 10(6): 1503-1518, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695506
7.
A conserved polylysine motif in CD86 cytoplasmic tail is necessary for cytoskeletal association and effective co-stimulation.
Biochem Biophys Res Commun
; 423(2): 301-7, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22659416
8.
CD80 and CD86 IgC domains are important for quaternary structure, receptor binding and co-signaling function.
Immunol Lett
; 161(1): 65-75, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24845157
Resultados
1 -
8
de 8
1
Próxima >
>>